VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LEGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LEGNLegend Biotech Corporation
$28.04$5.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLEGNQuarterly Financials

Legend Biotech Corporation (LEGN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Legend Biotech Corporation (LEGN) quarterly income statement — complete revenue, gross profit & net income history

LEGN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue305.1M306.38M272.33M255.06M195.05M186.52M160.21M186.52M93.99M79.46M96.01M73.33M36.34M27.63M27.36M11.97M41.33M38.99M17.04M20.83M
Revenue Growth %56.42%64.26%69.99%36.74%107.52%134.73%66.86%154.36%158.67%187.57%250.91%512.56%-12.09%-29.14%60.6%-42.54%188.95%-5.35%36.72%79.6%
Cost of Goods Sold175.9M123.46M115.31M97.99M71.34M73.92M55.47M50.45M54.74M32.45M48.65M128.46M35.61M28.21M129.98M16.94M81.35M000
COGS % of Revenue57.65%40.3%42.34%38.42%36.58%39.63%34.62%27.05%58.24%40.84%50.67%175.18%98.01%102.1%475.04%141.5%196.81%---
Gross Profit129.2M182.92M157.02M157.07M123.71M112.6M104.74M136.07M39.25M47.01M47.36M-55.13M723K-580K-102.62M-4.97M-40.01M38.99M17.04M20.83M
Gross Margin %42.35%59.7%57.66%61.58%63.42%60.37%65.38%72.95%41.76%59.16%49.33%-75.18%1.99%-2.1%-375.04%-41.5%-96.81%100%100%100%
Gross Profit Growth %4.44%62.45%49.92%15.43%215.17%139.5%121.13%346.81%5329.05%8205.88%146.16%-1009.76%101.81%-101.49%-702.31%-123.85%29.51%-5.35%36.72%79.6%
Operating Expenses179M203.52M200.48M178.95M174.36M187M174.79M178.04M157.12M166.86M139.89M144.97M124.34M128.01M146.61M114.32M115.31M156.2M103.65M109.49M
OpEx % of Revenue58.67%66.43%73.62%70.16%89.39%100.25%109.1%95.45%167.16%209.99%145.69%197.7%342.19%463.25%535.84%954.95%278.97%400.56%608.39%525.53%
Selling, General & Admin90.1M101.19M87.33M80.65M72.43M83.13M79.57M65.42M56.15M62.38M44.03M49.18M40.16M47.26M42.09M45.49M33.96M69.95M31.34M26.03M
SG&A % of Revenue29.53%33.03%32.07%31.62%37.13%44.57%49.67%35.07%59.74%78.51%45.86%67.07%110.52%171.01%153.85%380%82.16%179.39%183.94%124.94%
Research & Development85.96M101.33M113.15M98.3M101.92M104.43M95.52M112.63M100.96M105.68M95.86M95.79M84.89M80.76M104.52M68.83M81.35M86.5M72.31M83.46M
R&D % of Revenue28.17%33.07%41.55%38.54%52.25%55.99%59.62%60.38%107.42%132.99%99.84%130.63%233.62%292.24%381.99%574.95%196.81%221.83%424.45%400.58%
Other Operating Expenses1000K1000K000-563K-306K00-1000K00-710K0000-258K00
Operating Income-49.8M-20.6M-43.45M-21.88M-50.65M-74.39M-70.05M-41.97M-117.86M-119.85M-92.52M-200.11M-123.61M-128.59M-249.23M-119.28M-155.32M-117.2M-86.61M-88.65M
Operating Margin %-16.32%-6.72%-15.96%-8.58%-25.97%-39.89%-43.73%-22.5%-125.4%-150.82%-96.37%-272.88%-340.2%-465.35%-910.89%-996.45%-375.78%-300.56%-508.39%-425.53%
Operating Income Growth %1.67%72.31%37.97%47.87%57.03%37.93%24.29%79.03%4.65%6.8%62.88%-67.75%20.41%-9.72%-187.74%-34.55%-3.55%-98.36%-30.21%-58.22%
EBITDA-34.2M-8.63M-37.57M-16.03M-45.45M-67.6M-64.58M-36.6M-112.14M-114.5M-87.35M-197.92M-118.43M-123.34M-246.28M-115.18M-152.14M-113.49M-83.85M-85.96M
EBITDA Margin %-11.21%-2.82%-13.8%-6.28%-23.3%-36.24%-40.31%-19.62%-119.31%-144.09%-90.98%-269.91%-325.94%-446.36%-900.13%-962.15%-368.09%-291.04%-492.15%-412.59%
EBITDA Growth %24.75%87.23%41.82%56.21%59.47%40.96%26.07%81.51%5.31%7.17%64.53%-71.84%22.15%-8.68%-193.73%-33.99%-3.37%-96.59%-30.91%-61.49%
D&A (Non-Cash Add-back)15.6M11.97M5.88M5.85M5.2M6.8M5.47M5.37M5.72M5.35M5.17M2.18M5.18M5.25M2.94M4.11M3.18M3.71M2.77M2.7M
EBIT-47.6M-14.12M-39.07M-119.58M-94.07M45.66M-115.38M-12.49M-54.31M-140.99M-56.82M-104.31M-106.86M-130.86M-144.71M-191.43M-73.97M-87.73M-87.2M-87.81M
Net Interest Income1.8M2.47M4.03M5.23M7M8.5M11.13M11.56M8.39M11.48M12.74M-5.18M1.64M28K-3.25M-1.64M-1.04M-179K113K-52K
Interest Income7.3M7.95M9.67M10.47M12.06M13.65M16.63M17.05M13.87M17.3M18.42M-6.75M4.89M-0-423K321K0
Interest Expense5.5M5.48M5.64M5.24M5.06M5.15M5.5M5.48M5.47M5.82M5.68M5.18M5.11M4.86M3.25M1.64M1.04M602K208K52K
Other Income/Expense-3.3M1M4.38M-102.92M-48.48M114.91M-50.84M24M58.08M-26.96M30.03M1.27M11.64M-7.13M164.42M-73.79M114.23M28.87M-38.78M-2.93M
Pretax Income-53.1M-19.6M-39.07M-124.8M-99.13M40.51M-120.89M-17.97M-59.79M-146.81M-62.49M-198.84M-111.97M-135.72M-84.8M-193.07M-41.09M-88.33M-125.39M-91.58M
Pretax Margin %-17.4%-6.4%-14.35%-48.93%-50.82%21.72%-75.46%-9.63%-63.61%-184.75%-65.09%-271.16%-308.16%-491.16%-309.94%-1612.82%-99.41%-226.53%-736%-439.58%
Income Tax1.2M11.22M616K582K1.79M14.23M4.43M226K5K-1.99M-288K290K128K153K152K157K0001K
Effective Tax Rate %-2.26%-57.23%-1.58%-0.47%-1.8%35.12%-3.67%-1.26%-0.01%1.36%0.46%-0.15%-0.11%-0.11%-0.18%-0.08%0%0%0%-0%
Net Income-54.3M-30.82M-39.69M-125.38M-100.92M26.28M-125.32M-18.2M-59.79M-144.82M-62.21M-199.13M-112.1M-135.88M-84.96M-193.23M-41.09M-88.33M-125.39M-91.58M
Net Margin %-17.8%-10.06%-14.57%-49.16%-51.74%14.09%-78.23%-9.76%-63.62%-182.24%-64.79%-271.55%-308.51%-491.72%-310.5%-1614.13%-99.41%-226.53%-736%-439.59%
Net Income Growth %46.19%-217.24%68.33%-589.05%-68.78%118.15%-101.46%90.86%46.66%-6.58%26.78%-3.05%-172.84%-53.82%32.25%-110.98%49.21%-52.76%-88.43%32.1%
Net Income (Continuing)-54.3M-30.82M-39.69M-125.38M-100.92M26.28M-125.32M-18.2M-59.79M-144.82M-62.21M-199.13M-112.1M-135.88M-84.96M-193.23M-41.09M-88.33M-125.39M-91.58M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.30-0.17-0.22-0.68-0.550.14-0.68-0.10-0.33-0.80-0.34-1.14-0.68-0.85-0.54-1.25-0.27-0.60-0.87-0.66
EPS Growth %45.45%-221.43%67.65%-582.73%-66.67%117.5%-100%91.26%51.47%5.88%37.04%8.8%-151.85%-41.67%37.93%-89.39%55.74%-36.36%-74%47.2%
EPS (Basic)-0.30-0.17-0.21-0.68-0.550.14-0.68-0.10-0.33-0.80-0.34-1.14-0.68-0.85-0.54-1.25-0.27-0.60-0.87-0.66
Diluted Shares Outstanding184.73M184.73M184.64M184.14M183.76M182.85M182.73M182.6M182.01M181.91M181.79M175.26M165.25M159.04M156.97M154.89M154.35M146.6M144.96M138.51M
Basic Shares Outstanding184.73M184.73M180.41M184.14M183.76M182.85M182.73M182.6M182.01M181.91M181.79M175.26M165.25M159.04M156.97M154.89M154.35M146.6M144.96M138.51M
Dividend Payout Ratio--------------------